Sentongo Timothy A
Division of Gastroenterology, Hepatology, and Nutrition, Northwestern University, Feinberg School of Medicine, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614, USA.
Curr Gastroenterol Rep. 2004 Aug;6(4):307-13. doi: 10.1007/s11894-004-0083-5.
The observation that the intestinal Na(+)-glucose cotransporter remains intact in most diarrheal illnesses led to development of the life-saving, low-cost technology of oral rehydration salt (ORS) solutions. The primary therapeutic role of ORS solutions is in prevention and treatment of dehydration during management of acute gastroenteritis. Successful oral rehydration therapy involves early use of ORS with maintenance or timely resumption of regular feeding. Since the inception of the oral rehydration approach more than three decades ago, the widespread use of ORS solutions has revolutionized the management and outcomes of acute gastroenteritis in children and adults. The efficacy of the World Health Organization ORS solution and of commercial ORS formulations has been enhanced by reducing osmolarity. Newer formulations of ORS are under active investigation, with promise of added benefits, including promotion of intestinal healing. This article reviews fluid and electrolyte transport in the gastrointestinal tract, the pathophysiologic mechanisms of acute diarrhea, and the basis and formulation of current and newer ORS solutions. Guidelines for efficacious use of ORS in the management of acute gastroenteritis and short gut syndrome are also provided.
肠道钠-葡萄糖共转运体在大多数腹泻疾病中保持完好无损这一观察结果,促成了口服补液盐(ORS)溶液这项挽救生命且成本低廉的技术的发展。ORS溶液的主要治疗作用在于预防和治疗急性胃肠炎管理期间的脱水。成功的口服补液疗法包括早期使用ORS并维持或及时恢复正常喂养。自三十多年前口服补液方法问世以来,ORS溶液的广泛使用彻底改变了儿童和成人急性胃肠炎的管理方式及治疗结果。通过降低渗透压,世界卫生组织ORS溶液及商业ORS制剂的疗效得到了提高。新型ORS制剂正在积极研究中,有望带来更多益处,包括促进肠道愈合。本文回顾了胃肠道中的液体和电解质转运、急性腹泻的病理生理机制以及当前和新型ORS溶液的基础与配方。还提供了在急性胃肠炎和短肠综合征管理中有效使用ORS的指南。